TickerFacts.

Aspira Women's Health Inc. (AWHL): Cost of Revenue

Annual figures by period end, from SEC filings.

$3.30M
Year ended 2025-12-31
$3.52M
Trailing 12 months to 2026-06-30
-5.1%
3-year compound annual growth
-0.7%
5-year compound annual growth
+3.6%
10-year compound annual growth
$3.89M2010-12-31: $88.0K2011-12-31: $129.0K2012-12-31: $131.0K2013-12-31: $170.0K2015-12-31: $2.31M2016-12-31: $2.70M2017-12-31: $2.91M2018-12-31: $3.14M2019-12-31: $3.34M2020-12-31: $3.42M2021-12-31: $3.75M2022-12-31: $3.86M2023-12-31: $3.89M2024-12-31: $3.70M2025-12-31: $3.30M$3.30M
2010-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$3.30M-10.9%2026-04-01, From 2025-01-01
2024-12-31$3.70M-4.9%2026-04-01, From 2024-01-01
2023-12-31$3.89M+0.8%2025-03-27, From 2023-01-01
2022-12-31$3.86M+3.0%2024-04-01, From 2022-01-01
2021-12-31$3.75M+9.8%2023-10-26, From 2021-01-01
2020-12-31$3.42M+2.2%2022-03-31, From 2020-01-01
2019-12-31$3.34M+6.4%2021-03-31, From 2019-01-01
2018-12-31$3.14M+7.8%2020-04-07, From 2018-01-01
2017-12-31$2.91M+8.0%2019-03-28, From 2017-01-01
2016-12-31$2.70M+16.8%2018-03-13, From 2016-01-01
2015-12-31$2.31Mn/a2017-03-31, From 2015-01-01
No annual figure between 2013-12-31 and 2015-12-31.
2013-12-31$170.0K+29.8%2014-03-31, From 2013-01-01
2012-12-31$131.0K+1.6%2014-03-31, From 2012-01-01
2011-12-31$129.0K+46.6%2013-03-01, From 2011-01-01
2010-12-31$88.0Kn/a2012-03-27, From 2010-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Aspira Women's Health Inc. (AWHL)2025-12-31$3.30M-10.9%
Anbio Biotechnology (NNNN)2025-12-31$1.10M-52.0%
Biomerica Inc (BMRA)2026-05-31$4.09M-15.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$1.75M+66.2%
Immucell Corp (ICCC)2025-12-31$16.20M-12.7%
Alpha Teknova, Inc. (TKNO)2025-12-31$27.08M-11.3%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$200.0K0.0%
Myriad Genetics Inc (MYGN)2025-12-31$247.90M-1.7%
Neogen Corp (NEOG)2026-05-31$461.90M-2.4%

Compare AWHL, NNNN, BMRA, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗